A dimer peptide ligand of vascular endothelial growth factor slows the progression of human gastric tumors in mouse xenografts

Xiaoqing Ye, Haofeng Hu, Yilei He, Fei Ye, Jia Jin, Elodie Olivier, Jean-François Gaucher, Lei Wang · 2026

Read A dimer peptide ligand of vascular endothelial growth factor slows the progression of human gastric tumors in mouse xenografts by Xiaoqing Ye, Haofeng Hu, Yilei He, Fei Ye, Jia Jin, Elodie Olivier, Jean-François Gaucher, Lei Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0344142.txt.

Description

Xiaoqing Ye and seven colleagues published this 2026 cancer study testing a small peptide against stomach tumors. Drugs that block the growth factor VEGF can slow new blood vessels feeding a tumor, but the antibody versions are large and reach tissue poorly. A doubled peptide called D6, designed to grip VEGF, was their smaller alternative.

In cell tests and in mice carrying human stomach tumors, D6 slowed growth about as well as the standard antibody used for comparison. The catch was dose: the peptide needed repeated injections at higher amounts. Ye's group is now refining the molecule toward a more practical treatment.

Catalog record

CREATORXiaoqing Ye, Haofeng Hu, Yilei He, Fei Ye, Jia Jin, Elodie Olivier, Jean-François Gaucher, Lei Wang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26603
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0344142

Browse the full library · About the Tower of Babel